UVEITIS TREATMENT MARKET ANALYSIS

Uveitis Treatment Market, by Treatment Type (Corticosteroids, Immunosuppressant, Monoclonal Antibodies, Cycloplegic Agents, Antibiotics, Antivirals, Antifungal, Analgesics), by Disease type (Anterior Uveitis, Posterior Uveitis, Intermediate Uveitis, Pan uveitis), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Aug 2020
Code : CMI1094
Pages :186
Formats :
Excel and PDF
Industry : Medical Devices

Market Challenges And Opportunities

Global Uveitis Treatment Market– Drivers

High prevalence of uveitis is expected to propel growth of the global uveitis treatment over the forecast period. For instance, an article published in Frontiers in Medicine on September 10, 2021, the Pacific Ocular Inflammation Study found an annual incidence of uveitis of 24.9, while the Northern California study found an incidence of 52.4 cases of uveitis per 100,000 person-years.

The increase in high incidence of autoimmune disorders is expected to boost the growth of global uveitis treatment market over the forecast period. For instance, according to study done by John Hopkins University, department of pathology estimates suggest that all autoimmune diseases combined affect about 3% of the U.S. population every year, thus approximately 10 million people.

Global Uveitis Treatment Market: Restraint

The challenging manufacturing process is expected to hinder the growth of global uveitis treatment over the forecast period. For instance, eye care product needs unique manufacturing process for making the product appropriately aligned with the GMP regulations for sterile products. Since the formulations are prone to get affected by the pathogens available in the environment, they are formulated under highly protected area.